Tissue-specific regulation of checkpoint kinase 2 expression by p53

Experimental and Molecular Pathology

Volumn 75, Issue 2, 2003, Pages 131-136

  Chin, Mei Yieng ^a   Li, Gang ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b JACK BELL RESEARCH CENTRE   (Canada)

Author keywords

Chk2; Gene expression; P53; Tumor suppressor

Indexed keywords

CHECKPOINT KINASE 2; PHOSPHOTRANSFERASE; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; EMBRYO; HEART; IMMUNOHISTOCHEMISTRY; KIDNEY; KNOCKOUT MOUSE; LIVER; LUNG; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; SPLEEN; TESTIS; TISSUE DISTRIBUTION; WESTERN BLOTTING;

EID: 0141851077     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4800(03)00088-1     Document Type: Article

References (41)

1. Agarwal M.L., Agarwal A., Taylor W.R., Stark G.R. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA. 92:1995;8493-8497.
2. Ahn J.Y., Schwarz J.K., Piwinica-Worms H., Canman C.E. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res. 60:2000;5934-5936.
3. Ahn, J., Urist, M., Prives, C., 2003. Questioning the role of Chk2 in p53 DNA damage response. J. Biol. Chem., 278, 20480-20489.
4. Allen J.B., Zhou Z., Siede W., Friedberg E.C., Elledge S.J. The SADI/RAD53 protein kinase controls multiple checkpoints and DNA damaged-induced transcription in yeast. Genes Dev. 8:1994;2401-2415.
5. Balint E., Vousdon K.H. Activation and activities of the p53 tumor suppressor protein. Br. J. Cancer. 85:2001;1813-1823.
6. Bell D.W., Varley J.M., Szydlo T.E., Kang D.H., Wahrer D.C.R., Shannon K.E., Lubratovich M., Verselis S.J., Isselbacher K.J., Fraumeni J.F., Birch J.M., Li F.P., Garber J.E., Haber D.A. Heterozygous germline hChk2 mutations in Li-Fraumeni syndrome. Science. 286:1999;2528-2531.
7. Blasina A., Van de Weyer I., Laus M.C., Luyten W.H.M.L., Parker A.E., McGowan C.H. A human homologue of the checkpoint kinase Cds 1 directly inhibits Cdc25 phosphotase. Curr. Biol. 9:1999;1-10.
8. Brown A.L., Lee C.H., Schwarz J.K., Mitiku N., Piwnica-Worms H., Chung J.H. A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proc. Natl. Acad. Sci. USA. 96:1999;3745-3750.
9. Chao C., Saito S., Kang J., Anderson C.W., Appella E., Xu Y. p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBOJ. 19:2000;4967-4975.
10. Chehab N.H., Malikzay A., Appel M., Halazonetis T.D. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 14:2000;278-288.
11. Chehab N.H., Malikzay A., Stavridi E.S., Halazonetis T.D. Phosphorylation of Ser-20 mediates stabilization of p53 in response to DNA damage. Proc. Natl. Acad. Sci. USA. 96:1999;13777-13782.
12. Cheung K.J. Jr., Li G. Tissue-specific regulation of Chk1 expression by p53. Exp. Mol. Pathol. 71:2001;156-160.
13. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A. Jr., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature. 356:1992;215-221.
14. Elledge S.J. Cell cycle checkpoint preventing an identity crisis . Science. 274:1996;1664-1672.
15. Gottifredi V., Karni-Schmidt O., Shieh S.S., Prives C. p53 down-regulates Chk1 through p21 and the retinoblastoma protein. Mol. Cell. Biol. 21:2001;1066-1076.
16. Hermeking H., Lengauer C., Polyak K., He T.C., Zhang L., Thiagalingam S., Kinzler K.W., Vogelstein B. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell. 1:1997;3-11.
17. Hirao A., Kong Y.Y., Matsouka S., Wakeham A., Ruland J., Yoshida H., Liu D., Elledge S.J., Mak T.W. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science. 287:2000;1824-1827.
18. Ino Y., Wahrer D.C.R., Bell D.W., Haber D.A., Louis D.N. Mutation analysis of the hChk2 gene in primary human malignant gliomas. Neurogenetics. 3:2000;45-46.
19. Jallepalli, P.V., Lengauer, C., Vogelstein, B., Bunz, F., 2003. The Chk2 tumor suppressor is not required for p53 responses in human cancer cells, J. Biol. Chem., 278, 20475-20479.
20. Jimenez G.S., Nister M., Stommel J.M., Beeche M., Barcarse E.A., Zhang X., O'Gorman S., Wahl W. A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Nat. Genet. 26:2000;37-41.
21. Jin S., Antimore M.J., Lung F.D., Dong X., Zhao H., Fan F., Colchagie A.B., Blanck P., Roller P.P., Fornace A.J., Zhan Q. The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression. J. Biol. Chem. 275:2000;16602-16608.
22. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., Craig R.W. Participation of p53 in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
23. Lee S.B., Kim S.H., Bell D.W., Wahrer D.C.R., Schirip T.A., Korczak M.M., Sgroi D.C., Garber J.E., Li F.P., Nichols K.E., Varley J.M., Godwin A.K., Shannon K.M., Harlow E., Haber D.A. Destabilization of Chk2 by a missense mutation associated with Li-Fraumeni syndrome. Cancer Res. 61:2001;8062-8067.
24. Liu Q., Guntuku S., Cui X.S., Matsuoka S., Cortez D., Tamai K., Luo G., Carattini-Rivera S., DeMayo F., Bradley A., Donehower L.A., Elledge S.J. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev. 14:2000;1448-1459.
25. Matsuoka S., Nakagawa T., Masuda A., Haruki N., Elledge S.J., Takashi T. Reduced expression and impaired kinase activity of a Chk2 mutant identified in human lung cancer. Cancer Res. 61:2001;5362-5365.
26. Matsuoka S., Rotman G., Ogawa A., Shiloh Y., Tamai K., Elledge S.J. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. USA. 97:2000;10389-10394.
27. Matsuoka S., Huang M., Elledge S.J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science. 282:1998;1893-1897.
28. Meijers-Heijboer H., Van de Quweland A., Klijn J., Wasielewski M., de Snoo A., Oldenburg R., Hollestelle A., Houben M., Crepin E., Can Veghel-Plandsoen M., Elstrodt F., Van Duijn C. Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRAC1 or BRAC2 mutations. Nat. Genet. 31:2002;55-59.
29. Murakami H., Okayama H. A kinase from fission yeast responsible for blocking mitosis in S phase. Nature. 374:1995;817-819.
30. Nurse P. Checkpoint pathways come of age. Cell. 91:1997;865-867.
31. 2 checkpoint control regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine 216 . Science. 277:1997;1501-1505.
32. Poon R.Y., Chau M.S., Yamashita K., Hunter T. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res. 57:1997;5168-5178.
33. Rhind N., Russell P. Mitotic DNA damage and replication checkpoints in yeast. Curr. Opin. Cell Biol. 10:1998;749-758.
34. Sanchez Y., Wong C., Thoma R.S., Richman R., Wu Z., Piwnica-Worms H., Elledge S.J. Conversation of Chk1 checkpoint pathway in mammals linkage of DNA damage to Cdk regulation through Cdc25 . Science. 277:1997;1497-1501.
35. Sanchez Y., Bachant J., Wang H., Hu F., Liu D., Tetzlaff M., Elledge S.J. Control of DNA damage checkpoint by Chk1 and Rad53 protein kinases through distinct mechanisms. Science. 286:1999;1166-1171.
36. Shieh S.Y., Ahn J., Tamai K., Taya Y., Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14:2000;289-300.
37. Shigeishi H., Yakozaki H., Oue N., Kuniyasu H., Kando T., Ishikawa T., Yasui W. Increased expression of Chk2 in human gastric carcinomas harboring p53 mutations. Int. J. Cancer. 99:2002;58-62.
38. Tominaga K., Morisaki H., Kaneko Y., Fujimoto A., Tanak T., Ohtsubo M., Hirai M., Okawama H., Ikeda K., Nakanishi M. Role of human Cds1 (Chk2) kinase in DNA damage checkpoint and its regulation by p53. J. Biol. Chem. 274:1999;31463-31467.
39. Vahteristo P., Tamminen A., Karvinen P., Eerola H., Eklund C., Aaltonen L.A., Blomqvist C., Aittomaki K., Nevanlinna H. p53, Chk2 and Chk1 genes in Finnish families with Li-Fraumeni syndrome further evidence of Chk2 in inherited cancer predisposition . Cancer Res. 31:2001;5718-5722.
40. Walworth N., Davey S., Beach D. Fission yeast Chk1 protein kinase links the rad checkpoint pathway to cdc2. Nature. 363:1993;368-371.
41. Zeng Y., Forbes K.C., Wu Z., Moreno S., Piwnica-Worms H., Enoch T. Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1. Nature. 395:1998;507-510.